Pentixapharm Holding AG (ETR:PTP)
Germany · Delayed Price · Currency is EUR 2.500
+0.100 (4.17%)
At close: May 29, 2026
Pentixapharm Holding AG Revenue
Pentixapharm Holding AG had revenue of 59.00K EUR in the quarter ending March 31, 2026, a decrease of -68.62%. This brings the company's revenue in the last twelve months to 397.00K, down -58.47% year-over-year. In the year 2025, Pentixapharm Holding AG had annual revenue of 526.00K, down -74.37%.
Revenue (ttm)
397.00K
Revenue Growth
-58.47%
P/S Ratio
156.06
Revenue / Employee
11.03K
Employees
36
Market Cap
61.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 526.00K | -1.53M | -74.37% |
| Jan 1, 2025 | 2.05M | -4.46M | -68.49% |
| Dec 31, 2023 | 6.51M | 2.54M | 64.04% |
| Dec 31, 2022 | 3.97M | 1.37M | 52.67% |
| Dec 31, 2021 | 2.60M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.24B |
| Siemens Healthineers AG | 23.07B |
| Fresenius SE & Co. KGaA | 22.99B |
| Merck KGaA | 20.96B |
| FamiCord AG | 88.17M |
| DocCheck AG | 55.32M |
| LIMES Schlosskliniken AG | 50.00M |
| MeVis Medical Solutions AG | 15.48M |